Results 181 to 190 of about 197,714 (301)

Epidemiology changes in systemic lupus erythematosus in Italy: the EASIEST study. [PDF]

open access: yesLupus Sci Med
Gasparotto M   +16 more
europepmc   +1 more source

T cells, the Next Big Target in Axial Spondyloarthritis?

open access: yesArthritis &Rheumatology, EarlyView.
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley   +1 more source

The landscape of cellular immune alteration in systemic lupus erythematosus. [PDF]

open access: yesFront Immunol
Xiao J   +11 more
europepmc   +1 more source

A Pragmatic Trial of a Shared Decision‐Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ‐SAFE Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Hydroxychloroquine (HCQ) nonadherence in systemic lupus erythematosus (SLE) stemming from decision complexities can be improved with shared decision‐making (SDM) tools clarifying benefits and harms. This study aimed to develop and evaluate HCQ‐SAFE, a pictogram‐based SDM tool during SLE visits.
Caroline Packee   +8 more
wiley   +1 more source

Late-Onset Systemic Lupus Erythematosus: Is It Really a Benign Disease? [PDF]

open access: yesCureus
Santacruz JC   +6 more
europepmc   +1 more source

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General‐Population Cohort Analysis With Extended Quantile g‐Computation

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to investigate whether exposure to mixture of individual fine particulate matter (PM2.5) chemical constituents is associated with incident systemic lupus erythematosus (SLE) and if ozone modifies this association and/or is associated with SLE onset.
Naizhuo Zhao   +9 more
wiley   +1 more source

A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus. [PDF]

open access: yesJ Transl Autoimmun
Renaudineau Y   +12 more
europepmc   +1 more source

Systemic Lupus Erythematosus [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1971
openaire   +2 more sources

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Performance of common fetal growth standards in pregnancies affected by systemic lupus erythematosus. [PDF]

open access: yesRev Assoc Med Bras (1992)
Barros ACRP   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy